Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

ASX Announcements 2002

  • 22 Nov 2002

    Colorectal cancer trial commenced and Virion project (HIV) update

  • 16 Oct 2002

    Quarterly report 30 September 2002

  • 11 Oct 2002

    Financial Report for the year ended 30 June 2002

  • 10 Oct 2002

    ASX Announcement, Biotron successful in grant applications

  • 1 Oct 2002

    Notice of Annual General Meeting (Full notice)

  • 1 Oct 2002

    Notice of Annual General Meeting (Cover letter)

  • 13 Sep 2002

    Preliminary final report for the year ending 30th of June 2002

  • 28 Aug 2002

    Letter to ASX, Re:Independent Tests verify the company’s HIV compound to be effective and non-toxic

  • 28 Jun 2002

    Granting of options

  • 28 Jun 2002

    Exercising of options

  • 25 Jun 2002

    Appointment of a director

  • 31 May 2002

    Prostate Cancer Trial Commenced

  • 24 May 2002

    Company compound shown to inhibit HIV-1 replication

  • 11 Apr 2002

    Quarterly Report 31 March 2002

  • 25 Jan 2002

    Quarterly Report 30 December 2001

  • <<
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • >>

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 30 May 2022        Legal Notices and Privacy